EGFR and non-small cell lung carcinoma: Moreover, NK1R promotes non-small cell lung cancer progression through the transactivation of Epidermal Growth Factor Receptor (EGFR) [71] and acts as a promising biomarker and therapeutic target in breast cancer [72].